PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Spasticity and Movement Disorders "ReSTaRt" Unit, Physical Medicine and Rehabilitation Section, Policlinico Riuniti, University of Foggia, Foggia, Italy - andrea.santamato@unifg.it.\', \'"Fondazione Turati", Rehabilitation Center, Vieste, Foggia, Italy - andrea.santamato@unifg.it.\', \'Spasticity and Movement Disorders "ReSTaRt" Unit, Physical Medicine and Rehabilitation Section, Policlinico Riuniti, University of Foggia, Foggia, Italy.\', \'Department of Neurosciences, Neuromotor and Cognitive Rehabilitation Research Center, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.\', \'Villa Beretta Rehabilitation Center, Valduce Hospital, Costa Masnaga, Lecco, Italy.\', \'Physical Medicine and Rehabilitation Unit, Maggiore della Carità University Hospital, Department of Health Sciences, University of Eastern Piedmont "A. Avogadro", Novara, Italy.\', \'Neurorehabilitation Unit, Istituti Clinici Scientifici Maugeri, IRCCS, Institute of Bari, Bari, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.23736/S1973-9087.20.06478-3
?:doi
?:hasPublicationType
?:journal
  • European journal of physical and rehabilitation medicine
is ?:pmid of
?:pmid
?:pmid
  • 33263248
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.754
?:rankingScore_hIndex
  • 46
is ?:relation_isRelatedTo_publication of
?:title
  • Discontinuation of botulinum neurotoxin type-A treatment during COVID-19 pandemic: an Italian survey in post stroke and traumatic brain injury patients living with spasticity.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all